Overview
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.
Eligibility
Inclusion Criteria:
- Subjects who are able and willing to provide informed consent
- Aged 21 to 60 years at the time of consent
- Have a BMI within the range 18.0 to 32.0 kg/m2
- In general good health
Exclusion Criteria:
- Any condition, which in the investigator's opinion might jeopardize participant's safety or compliance with the protocol.
- Have clinically significant abnormalities on clinical laboratory results.
- Participation in other clinical trials recently/currently


